New Study Reveals Sacrix® Screws Significantly Outperform SI-Bone's iFuse® in Strength and Performance
Sacrix® Fully Threaded Screws: A Breakthrough in SI Joint Fusion
A recently published study in The Journal of Spine Surgery, led by orthopedic spine surgeon Dr. Kingsley R. Chin, sheds light on the enhanced effectiveness of Sacrix® fully threaded screws for sacroiliac joint (SIJ) fusion. With a staggering demonstrated performance of over 300% greater axial pullout strength than the traditional SI-Bone iFuse® implant, this research sets a new benchmark in orthopedic medical devices.
Insights from the Study
The study meticulously detailed the biomechanical properties of the Sacrix® screws, revealing their pullout strength to be 814.90 N (±99.4), as opposed to only 200.14 N (±14.4) for the iFuse® implants. This significant statistical difference (P<0.05) highlights not just an improvement, but a pivotal evolution in fixation technology. Remarkably, both devices maintain comparable surface areas, with Sacrix® sitting at 289.81 mm² against the iFuse® at 294.15 mm². Testing was conducted using the INSTRON 8874 Bi-Axial Tabletop System, ensuring reliable data collection.
A Historic Shift in Joint Fusion
In recent times, SI-Bone’s skeptics of screw-based fixation technologies have been forced to reconsider, especially as they are reportedly developing their own threaded screw system in retaliation to the evidence favoring Sacrix®. Dr. Chin himself notes the study’s findings revolutionize a long-standing narrative, affirming that “scientific, peer-reviewed proof” now supports the use of the Sacrix® screw for superior fixation outcomes.
The Future of SI Joint Fusion
The evolution of sacroiliac joint fusion procedures significantly leans towards outpatient settings. As demand increases for faster, less invasive surgical options, the Sacrix® screw recognizes these challenges, boasting features that promise optimized anchoring, reduced surgical time, and minimal tissue disruption—all under the guiding principles of LESS Exposure Spine Surgery philosophy.
Dr. Erik Spayde, a co-author of the study and Chief Medical Officer at NANISX, declares “Innovation wins”, emphasizing that the Sacrix® screw stems from a complete rethinking of SIJ fixation strategies. It asserts itself not just as a contender in the market, but as a trendsetter in surgical solutions.
Design and Development of Sacrix®
The Sacrix® screw is designed with the input from various specialists in the field including orthopedic surgeons, neurosurgeons, and interventional pain management experts. Their collaborative goal centers on adequately addressing three vital clinical challenges when engaging in outpatient spinal fusion:
1. Attaining robust biomechanical fixation that guarantees stability and fusion.
2. Ensuring self-tapping, self-drilling transarticular fixation that stabilizes the SI joint, preventing painful motion.
3. Implementing patented design elements, particularly for pre and post-harvesting of bone graft materials.
Leadership and Vision behind Sacrix®
Dr. Kingsley R. Chin plays a central role in this innovation as the Founder and CEO of KIC Ventures, which aims to advance outpatient spine surgery through its LESS™ philosophy. Knowledgeable through his Columbia engineering background and training from Harvard, Dr. Chin is a powerhouse in the orthopedic space with over 60 patents and a wealth of publications attributing to his innovative edge.
As part of KIC Ventures’ mission, the Sacrix® screw is developed within a robust portfolio that includes complementary products like InSpan®, FacetFuse®, and NanoFuse® Biologics. The overarching commitment of KIC Ventures is to truly revolutionize treatments in modern spine care.
Conclusion
In summary, the pivotal findings from this study not only affirm the superior performance of Sacrix® screws over older designs but signal a broader shift towards a new generation of surgical tools, which promise to reshape the future landscape of spinal surgeries. Such advancements present an exciting frontier for patients and medical professionals alike, pointing to a future where surgical interventions can be more effective, less invasive, and, importantly, more successful.